Jubilant Pharmova Ltd share price logo

Jubilant Pharmova Ltd (JUBLPHARMA)

₹7271.59%

bell
Get free price alerts. Set up your Free investment account to get Live Prices.
Overview
News
Financials
Q1 2024 Results
Technicals

Analyst Rating

based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts offering long term price targets for Jubilant Pharmova Ltd. An average target of ₹871

Source: S&P Global Market Intelligence

Jubilant Pharmova Ltd Share analysis

Source: S&P Global Market Intelligence

Performance

  • Day's Low

    Day's High

    ₹722.7
    ₹745.25
  • 52 Week's Low

    52 Week's High

    ₹318.75
    ₹780.3
1 Month Return-0.59 %
3 Month Return+ 9.32 %
1 Year Return+ 87.93 %
Previous Close₹738.75
Open₹738.75
Volume2.16L
Upper Circuit-
Lower Circuit-
Market Cap₹11,581.11Cr

Key Statistics

P/E Ratio149.28
PEG Ratio17.16
Market Cap₹11,581.11 Cr
P/B Ratio1.84
EPS31.431149987851

Mutual Fund Holdings

Funds HoldingsPrev. 6M
Quant Small Cap Fund Growth Option Direct PlanQuant Small Cap Fund Growth Option Direct Plan0.99%
HDFC Pharma and Healthcare Fund Direct GrowthHDFC Pharma and Healthcare Fund Direct Growth1.59%
Kotak Healthcare Fund Direct GrowthKotak Healthcare Fund Direct Growth2.04%
Nippon India Nifty Smallcap 250 Index Fund Dir GrNippon India Nifty Smallcap 250 Index Fund Dir Gr0.31%
JM Small Cap Fund Direct GrowthJM Small Cap Fund Direct Growth1.2%

Company Information

Jubilant Pharmova Ltd is a well-established and leading pharmaceutical company, listed on the Stock Exchange of India. It provides world-class and innovative products and solutions to its customers in the Indian and global markets. It has a sound and strong presence in both the domestic and international markets. The company is focused towards delivering excellent quality healthcare solutions with the highest standards of safety and efficacy. It has implemented stringent quality management systems as well as advanced research and development activities, which enable them to produce quality products meeting all applicable regulatory requirements. With its strong commitment towards delivering excellence, the company takes pride in setting a benchmark in the pharmaceutical industry.

Share Price: ₹727.00 per share as on 18 Jul, 2024 04:01 PM
Market Capitalisation: ₹11,581.11Cr as of today
Revenue: ₹1,746.40Cr as on March 2024 (Q1 24)
Net Profit: ₹-61.80Cr as on March 2024 (Q1 24)
Listing date: 09 Nov, 1994
Chairperson Name: Shyam S Bhartia
OrganisationJubilant Pharmova Ltd
HeadquartersNoida
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Jubilant Pharmova Ltd

  • Jubilant Pharmova Ltd witnesses 151.85 times surge in volume - 15 Jul, 2024

    Jubilant Pharmova Ltd saw a significant increase in trading volume, with 14 lakh shares traded on BSE by 10:47 IST, compared to the two-week average daily volume of 9221 shares. The stock increased 0.46% to Rs.725.00.

  • Jubilant Pharmova Subsidiary Repays Term Loan - 25 Jun, 2024

    Jubilant Pharma's subsidiary, Jubilant Pharma Holdings Inc., has completed the voluntary prepayment of a $75 million term loan, reducing its gross and net debt levels. The company reported a net loss of Rs 58.60 crore in Q4 FY24 but saw a YoY increase in total income. The stock rose by 0.08% to trade at Rs 732.90 on the BSE.

  • Jubilant Pharmova Shares Fall After Receiving Observations From USFDA - 18 Jun, 2024

    Jubilant Pharmova's shares fell by 4% after the company received 15 observations from the USFDA for its Montreal facility in Canada. The nature of the observations is unclear. In other news, Jubilant Pharmova reported a net loss of Rs 58.60 crore in March 2024 and a 4.8% YoY increase in net sales.

Insights on Jubilant Pharmova Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 1.59K Cr → 1.77K Cr (in ₹), with an average increase of 3.5% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 years, JUBLPHARMA stock has moved up by 2.9%

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 25.56% to 25.90% in Mar 2024 quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 1.50% to 2.27% in Mar 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Zydus Lifesciences Ltd has given 96.8% return, outperforming this stock by 11.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 129.1% return, outperforming this stock by 126.2%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 50.68% of holdings in Mar 2024 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 66.8 Cr → -58.6 Cr (in ₹), with an average decrease of 187.7% per quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 20.29% to 19.06% in Mar 2024 quarter

Company Financials

Value in ₹ crore
Q'1 24Q/Q Change
Revenue
₹1,746.40Cr
↑4.88%
Net Income
-₹61.80Cr
↓193.07%
Net Profit Margin
-3.54%
↓188.72%
2023Y/Y Change
Revenue
₹6,281.73Cr
↑2.47%
Net Income
-₹64.88Cr
↓115.71%
Net Profit Margin
-1.03%
↓115.28%
Value in ₹ crore
2023Y/Y Change
Total Assets
₹3,027.20Cr
↑65.47%
Total Liabilities
₹612.65Cr
↑11.87%
Value in ₹ crore
2023Y/Y Change
Operating Cash Flow
-₹65.12Cr
↑1,734.37%

Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
50.68%
0.00
Foreign Institutions
19.06%
0.00
Mutual Funds
2.27%
0.00
Retail Investors
25.9%
0.00
Others
2.09%
0.00

Key Indicators

Jubilant Pharmova Ltd Valuation

Jubilant Pharmova Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-195.50x)

December 29, 2023

Industry (57.08x)

July 18, 2024

Today (149.28x)

July 18, 2024

Highest (257.22x)

February 16, 2024

LowHigh

Earnings and Dividends

  • Jubilant Pharmova Ltd Earnings Results

    Jubilant Pharmova Ltd’s net profit jumped 40.14% since last year same period to ₹-58.60Cr in the Q4 2023-2024. On a quarterly growth basis, Jubilant Pharmova Ltd has generated -187.72% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Jubilant Pharmova Ltd Dividends May,2024

    In the quarter ending March 2024, Jubilant Pharmova Ltd has declared dividend of ₹5 - translating a dividend yield of 1.38%.

    Read More about Dividends

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Jubilant Pharmova Ltd is currently in a Bullish trading position according to technical analysis indicators.

Frequently Asked Questions

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Jubilant Pharmova Ltd shares.

Jubilant Pharmova Ltd (JUBLPHARMA) share price today is ₹727

Jubilant Pharmova Ltd is listed on NSE

Jubilant Pharmova Ltd is listed on BSE

  • Today’s highest price of Jubilant Pharmova Ltd is ₹745.25.
  • Today’s lowest price of Jubilant Pharmova Ltd is ₹722.7.

PE Ratio of Jubilant Pharmova Ltd is 149.28

PE ratio = Jubilant Pharmova Ltd Market price per share / Jubilant Pharmova Ltd Earnings per share

Today’s traded volume of Jubilant Pharmova Ltd(JUBLPHARMA) is 2.16L.

Today’s market capitalisation of Jubilant Pharmova Ltd(JUBLPHARMA) is ₹11581.11Cr.

Jubilant Pharmova Ltd(JUBLPHARMAPrice
52 Week High
₹780.3
52 Week Low
₹318.75

Jubilant Pharmova Ltd(JUBLPHARMA) share price is ₹727. It is down -6.83% from its 52 Week High price of ₹780.3

Jubilant Pharmova Ltd(JUBLPHARMA) share price is ₹727. It is up 128.08% from its 52 Week Low price of ₹318.75

Jubilant Pharmova Ltd(JUBLPHARMAReturns
1 Day Returns
-11.75%
1 Month Returns
-0.59%
3 Month Returns
9.32%
1 Year Returns
87.93%